CoreMedica is a diagnostic services company with operations in the US and EU. Founded 2010 in Lee’s Summit, Missouri, CoreMedica Labs spent its initial years developing the science, validating its methods, and implementing compliance to obtain College of American Pathologists (CAP) Accreditation and the Clinical Laboratory Improvement Amendments (CLIA) License. CoreMedica US is the first dried blood laboratory to receive CAP accreditation in 2014. The company provides a range of diagnostic services for corporate wellness, research, and pharmaceutical clients. In 2018 CoreMedica expanded its activities to Geneva, Switzerland to add the biological passport and innovative new technologies and intellectual property to its portfolio of services.

CoreMedica’s current specimen analysis capabilities span across multiple collection modalities and methods, fingerstick, or venipuncture. Specimens, from all across the world, are processed at both of its US & EU site laboratories daily. Its geographic footprint allows for industry leading turn-around time, consistency and quality.

Industries We Serve

CoreMedica serves many industries including, but not limited to:
Corporate Wellness • Epidemiological Research • Pharma • Clinical Trials Monitoring • Insurance Underwriting ​



Micro Analysis
Nimble Validation


Nationally Accredited
Proficiency Programs
Do It Right The Frist Time


We Put Our Customer First
Direct Access To Team
Resolution With Options


Relationship Driven
Centralized Consistency


Electronic Ordering
Customer Focused Reporting
HIPAA Complaint Portal

Mangement Team

A multi-talented group of laboratory directors and health & wellness market executives.


Jean-Marc Leroux, Ph.D

Chairman & CEO
Co-Founder of BioKaizen: 30+ years’ experience in diagnostic labs and clinical trials including serving as GM/Global Lab Ops and Chief Innovation Officer of Covance Business Drug Development of LabCorp


Pierre-Edouard Sotta, Ph.D

Director & Scientific Officer, Europe
Co-Founder BioKaizen. Father and developer of biological passport, 15+ years’ experience working with biological data and development of biomarkers.


Matt Combs

Chief Revenue Officer, North America
With more than 15 years of experience in healthcare and financial services industry. Executive experienced in operational, sales, new business and development strategies.


Jason Taber

Director of IT 
Senior level technical director with more than 15 years of experience in driving innovation through the planning, development, integration and support of technical and enterprise solutions aligned with evolving business capabilities for the real world of enterprise IT.


Cory Zuehlsdorf

COO & Director North America
Founded CoreMedica after a decade in various executive, operations, regulatory and product roles in the medical device and lab services industry.


Cristian Saez, Ph.D

Scientific Officer, North America
Over 20 years leading laboratories. Doctoral degree in Biochemistry & Molecular Genetics, Board Certified in Clinical Chemistry (NRCC) & lab management.


Steve Parks

VP, Finance & Administration
Accounting Executive in the planning, forecasting and budgeting, and project management for global lab operations. Former manager of accounting and planning for Clinical Reference Labs.


Bill Robert, Ph.D

Strategic Operations
Laboratory Executive with 30+ years executive experience in laboratory management and facility design. Overseas project management in R&D, IT and facility operations.

Our Mission: To deliver innovation for better health, worldwide.

Currently, blood samples must be collected by licensed phlebotomists, packed in break-proof, leak-proof containers, and shipped overnight.  Long distance transport may require the use of dry ice or liquid nitrogen and requires specialized handling and volume storage that increases costs significantly.

CoreMedica overcomes these issues with:

​1.     Minimally invasive testing (using capillary blood).
2.     Superior collection, handling & transport economics via compact blood.

3.     Greater safety and simplicity in collection, shipping, and disposal.
4.     Test-from-anywhere capabilities.